Wells Fargo & Company Anika Therapeutics, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 5,662 shares of ANIK stock, worth $91,950. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,662

Previous 6,107 7.29%

Holding current value

$91,950

Previous $154,000 9.74%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$24.25 - $28.75 $10,791 - $12,793	-445 Reduced 7.29%	5,662 $139,000
Q2 2024 Aug 13, 2024	BUY	$24.57 - $28.47 $22,874 - $26,505	931 Added 17.99%	6,107 $154,000
Q1 2024 May 10, 2024	BUY	$21.95 - $26.42 $14,552 - $17,516	663 Added 14.69%	5,176 $131,000
Q4 2023 Feb 09, 2024	BUY	$18.47 - $23.3 $7,221 - $9,110	391 Added 9.49%	4,513 $102,000
Q3 2023 Nov 13, 2023	SELL	$16.98 - $26.1 $121,678 - $187,032	-7,166 Reduced 63.48%	4,122 $76,000
Q2 2023 Aug 15, 2023	BUY	$25.16 - $28.86 $73,819 - $84,675	2,934 Added 35.12%	11,288 $293,000
Q1 2023 May 12, 2023	BUY	$25.91 - $32.1 $199,144 - $246,720	7,686 Added 1150.6%	8,354 $239,000
Q4 2022 Feb 13, 2023	SELL	$23.85 - $31.91 $17,434 - $23,326	-731 Reduced 52.25%	668 $19,000
Q3 2022 Nov 14, 2022	SELL	$21.74 - $24.68 $8,217 - $9,329	-378 Reduced 21.27%	1,399 $33,000
Q2 2022 Aug 12, 2022	SELL	$20.4 - $25.53 $290,128 - $363,087	-14,222 Reduced 88.89%	1,777 $39,000
Q1 2022 May 16, 2022	SELL	$24.7 - $36.54 $103,789 - $153,541	-4,202 Reduced 20.8%	15,999 $403,000
Q4 2021 Feb 14, 2022	SELL	$35.83 - $45.03 $521,935 - $655,952	-14,567 Reduced 41.9%	20,201 $724,000
Q3 2021 Nov 15, 2021	BUY	$38.75 - $44.47 $120,435 - $138,212	3,108 Added 9.82%	34,768 $1.48 Million
Q2 2021 Aug 16, 2021	BUY	$39.42 - $48.08 $861,524 - $1.05 Million	21,855 Added 222.9%	31,660 $1.37 Million
Q1 2021 May 13, 2021	SELL	$32.49 - $45.96 $6.05 Million - $8.55 Million	-186,065 Reduced 94.99%	9,805 $400,000
Q4 2020 Feb 09, 2021	BUY	$32.59 - $45.26 $90,958 - $126,320	2,791 Added 1.45%	195,870 $8.87 Million
Q3 2020 Nov 05, 2020	SELL	$32.56 - $38.57 $189,173 - $224,091	-5,810 Reduced 2.92%	193,079 $6.83 Million
Q2 2020 Aug 13, 2020	SELL	$27.83 - $37.73 $1.09 Million - $1.48 Million	-39,177 Reduced 16.46%	198,889 $7.51 Million
Q1 2020 May 14, 2020	BUY	$22.38 - $54.06 $5.33 Million - $12.9 Million	238,066 New	238,066 $6.88 Million

Others Institutions Holding ANIK

# of Institutions

123

Shares Held

11.5M

Call Options Held

200

Put Options Held

100

View Full List

About Anika Therapeutics, Inc.

Ticker ANIK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,599,900
Market Cap $237M
Description
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...

More about ANIK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Anika Therapeutics, Inc. Transaction History